Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| ARUP Laboratories, |
RCV001595020 | SCV007330291 | benign | not provided | 2025-04-08 | criteria provided, single submitter | clinical testing | |
| Mayo Clinic Laboratories, |
RCV001288849 | SCV007315268 | benign | not specified | 2023-04-21 | criteria provided, single submitter | clinical testing | BS1, BS2, BP4 |
| Gene |
RCV001595020 | SCV001829660 | benign | not provided | 2021-09-16 | criteria provided, single submitter | clinical testing | |
| Athena Diagnostics | RCV001288849 | SCV001476239 | benign | not specified | 2020-08-10 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000548562 | SCV000660124 | benign | Early-onset Parkinson disease 20; Developmental and epileptic encephalopathy, 53 | 2026-01-28 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV003915655 | SCV004729182 | benign | SYNJ1-related disorder | 2019-06-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |